A Safety Study of ARRY-371797 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2012
At a glance
- Drugs ARRY 797 (Primary)
- Indications Ankylosing spondylitis; Cancer; Dental pain; Musculoskeletal pain; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- 23 Apr 2012 Actual patient number 40 added as reported by ClinicalTrials.gov.
- 09 Feb 2009 New source identified and integrated (ClinicalTrials.gov): planned end date is now 1 Jan 2009.
- 25 Nov 2007 New trial record.